(CAS) Cascades - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA1469001053
CAS: Packaging, Tissue, Containerboard, Boxboards, Papers
Cascades Inc. is a leader in the packaging and tissue products industry, operating primarily in Canada and the United States. Founded in 1964 and headquartered in Kingsey Falls, Canada, the company has established itself as a significant player in sustainable packaging solutions. Cascades specializes in producing, converting, and marketing products made from recycled fibers, which not only aligns with environmental sustainability trends but also appeals to eco-conscious consumers and investors focused on ESG factors.
The company operates through three distinct segments: Containerboard, Specialty Products, and Tissue Papers. The Containerboard segment produces essential packaging materials, catering to industries that require robust and reliable packaging solutions. This segment is crucial as packaging demand remains consistent across various sectors. The Specialty Products segment offers niche solutions, such as uncoated recycled boxboards, diversifying the companys revenue streams and addressing specific market needs. The Tissue Papers segment provides staple products, ensuring a steady market presence due to consistent consumer demand.
Cascades commitment to sustainability is evident through its recovery and recycling activities, which contribute to a closed-loop production process. This approach not only enhances environmental efficiency but also supports cost management and margin maintenance, appealing to investors seeking both sustainability and financial performance.
From a financial perspective, Cascades has a market capitalization of approximately 1.3 billion CAD. The price-to-book (P/B) ratio of 0.76 may indicate undervaluation, suggesting potential for investors. The price-to-sales (P/S) ratio of 0.28 highlights efficient revenue generation per share. With a forward price-to-earnings (P/E) ratio of 8.37, the company presents a balanced outlook, combining current stability with future growth expectations. These metrics position Cascades as an attractive option for investors seeking exposure to the packaging and tissue products sector with a focus on sustainability and operational efficiency.
Additional Sources for CAS Stock
CAS Stock Overview
Market Cap in USD | 836m |
Sector | Consumer Cyclical |
Industry | Packaging & Containers |
GiC Sub-Industry | Paper & Plastic Packaging Products & Materials |
IPO / Inception |
CAS Stock Ratings
Growth 5y | 11.3% |
Fundamental | -20.2% |
Dividend | 70.9% |
Rel. Strength Industry | -22.6 |
Analysts | - |
Fair Price Momentum | 10.69 CAD |
Fair Price DCF | 38.80 CAD |
CAS Dividends
Dividend Yield 12m | 4.43% |
Yield on Cost 5y | 5.11% |
Annual Growth 5y | 8.45% |
Payout Consistency | 96.0% |
CAS Growth Ratios
Growth Correlation 3m | 58.4% |
Growth Correlation 12m | 73.1% |
Growth Correlation 5y | -35.2% |
CAGR 5y | 4.01% |
CAGR/Max DD 5y | 0.08 |
Sharpe Ratio 12m | 0.40 |
Alpha | -6.02 |
Beta | 0.87 |
Volatility | 28.95% |
Current Volume | 278.4k |
Average Volume 20d | 302.8k |
As of February 22, 2025, the stock is trading at CAD 11.44 with a total of 278,435 shares traded.
Over the past week, the price has changed by -10.90%, over one month by -9.92%, over three months by +2.60% and over the past year by -18.83%.
Neither. Based on ValueRay Fundamental Analyses, Cascades is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.20 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAS as of February 2025 is 10.69. This means that CAS is currently overvalued and has a potential downside of -6.56%.
Cascades has no consensus analysts rating.
According to ValueRays Forecast Model, CAS Cascades will be worth about 11.8 in February 2026. The stock is currently trading at 11.44. This means that the stock has a potential upside of +3.06%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14.1 | 23.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 11.8 | 3.1% |